GlassScriptPhysician profile
Esa Rayyan
NPI 1699160572
$1,106.84
in general payments reported to CMS, 2019-2025
7 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $32.76 · 2022: $46.61 · 2023: $380 · 2024: $218 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $554.95 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pulmonx Corporation | $185.71 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| La Jolla Pharmaceutical Company | $125.50 | 2025 | Giapreza |
| Genentech USA, INC. | $120.69 | 2019 | |
| Getinge USA Sales, LLC | $98.42 | 2021-2023 | Cardiohelp |
| Baxter Healthcare | $21.57 | 2025 | Hillrom - Vest System Model 105 Home Care |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esa Rayyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.